| Patient | Jackie Robinson |
|---|---|
| Date of birth | 1919-01-31 |
| Identifiers | MRN HR-ML037-SYN-TD; SSN (made up) 000-37-2286 |
| Document date | 1971-07-27 |
| Author | Marcus Delacroix-Hale, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for visit for blurred vision and new floaters, chest tightness on stairs, calf pain on walking and numb feet, in a man with long-standing diabetes six weeks after the death of his son. [S]
Hemoglobin A1c: 10.4% (high); Glucose (random): 248 mg/dL (high); Sodium: 137 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 1.12 mg/dL; eGFR (CKD-EPI 1966, race-free): 79 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 86 mg/g (high); Total cholesterol: 226 mg/dL (high); LDL cholesterol: 142 mg/dL (high); HDL cholesterol: 38 mg/dL (low); Triglycerides: 230 mg/dL (high); ALT: 28 U/L; AST: 24 U/L; Hemoglobin: 13.9 g/dL; Platelets: 250 10*3/uL; Vitamin B12: 380 pg/mL; TSH: 1.8 mIU/L; PHQ-9: 9. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1971-07-27 | Body height | 180 | cm | S |
| 1971-07-27 | Body weight | 104 | kg | S |
| 1971-07-27 | Body mass index (BMI) [Ratio] | 32.1 | kg/m2 | S |
| 1971-07-27 | Systolic blood pressure | 152 | mm[Hg] | S |
| 1971-07-27 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 1971-07-27 | Heart rate | 84 | /min | S |
| 1971-07-27 | Respiratory rate | 16 | /min | S |
| 1971-07-27 | Body temperature | 36.7 | Cel | S |
| 1971-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1971-07-27 | Hemoglobin A1c/Hemoglobin.total in Blood | 10.4 | % | Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually | High | S |
| 1971-07-27 | Glucose [Mass/volume] in Serum or Plasma | 248 | mg/dL | 70-139 mg/dL | High | S |
| 1971-07-27 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1971-07-27 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1971-07-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1971-07-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M | 79 | mL/min/{1.73_m2} | 90 or higher is normal; 60 to 89 is mildly decreased (G2) | Low | S |
| 1971-07-27 | Albumin/Creatinine [Mass Ratio] in Urine | 86 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2) | High | S |
| 1971-07-27 | Cholesterol [Mass/volume] in Serum or Plasma | 226 | mg/dL | <=199 mg/dL | High | S |
| 1971-07-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | Goal below 55 mg/dL with atherosclerotic disease | High | S |
| 1971-07-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 1971-07-27 | Triglyceride [Mass/volume] in Serum or Plasma | 230 | mg/dL | <=149 mg/dL | High | S |
| 1971-07-27 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-55 U/L | Normal | S |
| 1971-07-27 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 8-48 U/L | Normal | S |
| 1971-07-27 | Hemoglobin [Mass/volume] in Blood | 13.9 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1971-07-27 | Platelets [#/volume] in Blood by Automated count | 250 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1971-07-27 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 380 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1971-07-27 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1971-07-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 1970-03-03 | active | S |
| Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70 | At bedtime, by the gradual titration plan | Subcutaneous route | 1970-03-03 | active | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1970-03-03 to 1971-07-29 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake) | One tablet daily | Oral route | 1971-07-27 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1970-03-03 | active | S |
| Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes | As needed for severe low blood sugar | Nasal route | 1971-07-27 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged | active | confirmed | H53.8 | S — Synthetic presenting finding, superseded by the retinal diagnosis two days later. |
| Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged | active | confirmed | R07.89 | S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test. |
| Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%) | active | confirmed | E11.65 | S — Synthetic modern episode linked to his documented diabetes. |
| Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg) | active | confirmed | I12.9 | S — Synthetic modern episode linked to his documented high blood pressure. |
| Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79 | active | confirmed | E11.22 | S — Synthetic kidney findings. |
| Chronic kidney disease G2 A2 | active | confirmed | N18.2 | S — Synthetic kidney finding. |
| Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses | active | confirmed | E11.51 | S — Synthetic modern episode linked to the documented artery damage in his legs. |
| Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing | active | confirmed | E11.42 | S — Synthetic modern episode linked to the documented nerve damage in his legs. |
| History of two mild strokes a year ago, without lasting weakness | active | confirmed | Z86.73 | S — Synthetic modern coding of the documented strokes. |
| Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Bereavement: his eldest son died in a car crash six weeks ago | active | confirmed | Z63.4 | S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder. |